TY - JOUR
T1 - Relationship between IgM antibody to human cytomegalovirus, virus load, donor and recipient serostatus, and administration of methylprednisolone as risk factors for cytomegalovirus disease after liver transplantation
AU - Chou, Sunwen
AU - Miner, Richard C.
AU - Drew, W. Lawrence
N1 - Funding Information:
Financial support: supported in part by grants from the United Kingdom Medical Research Council, the Wellcome Trust, and the European Community (Biomed 2).
PY - 2000
Y1 - 2000
N2 - A patient with AIDS and cytomegalovirus (CMV) retinitis received ganciclovir and foscarnet for 20 and 5 months, respectively, with evidence of periodic disease progression. After this therapy, a CMV isolate from the patient was resistant to ganciclovir, foscarnet, and cidofovir. Sequence analysis showed a known ganciclovir resistance mutation in the viral UL97 phosphotransferase (L595F) and a new mutation in conserved region V of the DNA polymerase gene (pol) sequence (codons 981-982 deleted). The pol mutation was transferred to a laboratory CMV strain (Towne) by homologous recombination and selection with either ganciclovir or foscarnet. Recombinant viruses containing this deletion showed a 6-8-fold increased ganciclovir resistance and a 3-5-fold increased resistance to both foscarnet and cidofovir, compared with the wild-type CMV. A single mutation in region V of CMV pol can, therefore, confer multiple drug resistance in a clinical isolate.
AB - A patient with AIDS and cytomegalovirus (CMV) retinitis received ganciclovir and foscarnet for 20 and 5 months, respectively, with evidence of periodic disease progression. After this therapy, a CMV isolate from the patient was resistant to ganciclovir, foscarnet, and cidofovir. Sequence analysis showed a known ganciclovir resistance mutation in the viral UL97 phosphotransferase (L595F) and a new mutation in conserved region V of the DNA polymerase gene (pol) sequence (codons 981-982 deleted). The pol mutation was transferred to a laboratory CMV strain (Towne) by homologous recombination and selection with either ganciclovir or foscarnet. Recombinant viruses containing this deletion showed a 6-8-fold increased ganciclovir resistance and a 3-5-fold increased resistance to both foscarnet and cidofovir, compared with the wild-type CMV. A single mutation in region V of CMV pol can, therefore, confer multiple drug resistance in a clinical isolate.
UR - http://www.scopus.com/inward/record.url?scp=0033695834&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033695834&partnerID=8YFLogxK
U2 - 10.1086/317636
DO - 10.1086/317636
M3 - Article
C2 - 11069231
AN - SCOPUS:0033695834
SN - 0022-1899
VL - 182
SP - 1610
EP - 1615
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
IS - 6
ER -